1. Market Research
  2. > Pathology Industry

Breast Cancer Industry, May 2016 Market Reports from Top Publishers

You might be interested in: Diagnostics, Mammography, Therapeutics, Molecular Diagnostic, Pharmaceutical, Radiological Equipment, Vaccine, Biomarker, Biopsy Device, Healthcare, Antibody, Biosimilar, Cancer Diagnostic, Medical, Antigen, Biochip, Cancer Drug, Radiation Therapy, Therapy, Diagnostic.


 
1-10 of 78 reports for Breast Cancer

Purchase Reports From Reputable Market Research Publishers

Breast Cancer Treatment Drug Markets in China

Breast Cancer Treatment Drug Markets in China

  • $ 4 000
  • Industry report
  • March 2016
  • by Asia Market Information & Development Company

China's demand for Breast Cancer Treatment Drug has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high ...

Global Breast Cancer Partnering 2010 to 2016

Global Breast Cancer Partnering 2010 to 2016

  • $ 1 495
  • Industry report
  • April 2016
  • by Currentpartnering

The Global Therapy Partnering Terms and Agreements since 2010 report provides understanding and access to partnering deals and agreements entered into by the world’s leading healthcare companies. - Trends ...

Breast Cancer Treatment Drug Companies in China

Breast Cancer Treatment Drug Companies in China

  • $ 1 800
  • Industry report
  • March 2016
  • by Asia Market Information & Development Company

This study focuses on China’s Breast Cancer Treatment Drug industry assessments and company profiles. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions ...

Breast Cancer Treatment Drug Industry Forecasts - China Focus

Breast Cancer Treatment Drug Industry Forecasts - China Focus

  • $ 1 000
  • Industry report
  • March 2016
  • by Asia Market Information & Development Company

This study focuses on China’s Breast Cancer Treatment Drug industry forecasts. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities ...

Breast Cancer: Update Bulletin [March 2016]

Breast Cancer: Update Bulletin [March 2016]

  • $ 1 040
  • Industry report
  • March 2016
  • by Firstword Pharma

In this update KOLs reflect on the promising Phase Ib data for Roche’s monoclonal antibody (mAb), atezolizumab, in combination with nab-paclitaxel for patients with metastatic triple- negative breast ...

Frontier Pharma: Breast Cancer - First-in-Class Innovation Clustered Around Growth Factor Signalling Processes

Frontier Pharma: Breast Cancer - First-in-Class Innovation Clustered Around Growth Factor Signalling Processes

  • $ 6 995
  • Industry report
  • February 2016
  • by GBI Research

Frontier Pharma: Breast Cancer - First-in-Class Innovation Clustered Around Growth Factor Signalling Processes Summary The breast cancer pipeline is the largest in the pharmaceutical industry, with 1,050 ...

Breast Cancer Therapeutics in Asia-Pacific Markets to 2021 - Growth Driven by Increasing Uptake of Premium Priced Biologics and Rising Prevalence

Breast Cancer Therapeutics in Asia-Pacific Markets to 2021 - Growth Driven by Increasing Uptake of Premium Priced Biologics and Rising Prevalence

  • $ 4 995
  • Industry report
  • February 2016
  • by GBI Research

Breast Cancer Therapeutics in Asia-Pacific Markets to 2021 - Growth Driven by Increasing Uptake of Premium Priced Biologics and Rising Prevalence Summary Breast cancer, a malignant neoplasm, is the second-most ...

Breast Cancer Drug Pipeline Update

Breast Cancer Drug Pipeline Update

  • $ 3 375
  • Industry report
  • February 2016
  • by Bioseeker

Breast cancer is the leading cause of cancer-related mortality among women worldwide. High unmet needs still persist for this tumor type. Despite recent drug approvals in the adjuvant and metastatic setting, ...

Breast Cancer Drug Pathway Analyzer

Breast Cancer Drug Pathway Analyzer

  • $ 3 375
  • Industry report
  • February 2016
  • by Bioseeker

Extra value: One year of free online updates included with this product There are today at least 710 targeted molecular therapies known to affect more than 262 specific intracellular signaling pathways ...

Target Atlas in Breast Cancer: A Competitive Outlook

Target Atlas in Breast Cancer: A Competitive Outlook

  • $ 3 375
  • Industry report
  • February 2016
  • by Bioseeker

Extra value: One year of free online updates included with this product "Target Atlas in Breast Cancer: A Competitive Outlook" helps you to understand the complex world of commercial development in breast ...

About 7 300 reports for Breast Cancer

Download Unlimited Documents from Trusted Public Sources

Pathology Description in the US

  • January 2014
    186 pages
  • Breast Cancer  

    Cancer  

    Therapy  

  • United States  

View report >

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.